Tabriz University of Medical Sciences, Tabriz, Iran.
Health Informatics J. 2021 Jan-Mar;27(1):1460458221996409. doi: 10.1177/1460458221996409.
In order to understand if a physician prescribed medical information changes, the number of hospital readmission, and death among the heart failure patients. A 12-month randomized controlled trial was conducted (December 2013-2014). Totally, 120 patients were randomly allocated into two groups of intervention ( = 60) and control ( = 60). Accordingly, the control group was given the routine oral information by the nurse or physician, and the intervention group received the Information Prescription (IP) prescribed by the physician as well as the routine oral information. The data was collected via telephone interviews with the follow-up intervals of 6 and 12 months, and also for 1 year after the discharge. The patients with the median age of (IQR) 69.5 years old (19.8) death upon adjusting a Cox survival model, [RR = 0.67, 95%CI: 0.46-0.97]. Few patients died during 1 year in the intervention group compared to the controls (7 vs 15) [RR = 0.47, 95%CI: 0.20-1.06]. During a period of 6-month follow-up there was not statistically significant on death and readmission between two groups. Physician prescribed information was clinically and statistically effective on the reduction of death and hospital readmission rates among the HF patients in long term follow-up.
为了了解医生开具的医疗信息是否会改变心力衰竭患者的再住院率和死亡率，进行了一项为期 12 个月的随机对照试验（2013 年 12 月至 2014 年）。总共将 120 名患者随机分配到干预组（n=60）和对照组（n=60）。相应地，对照组由护士或医生提供常规口服信息，干预组由医生开具信息处方（IP）并提供常规口服信息。通过电话访谈收集数据，随访间隔为 6 个月和 12 个月，出院后随访 1 年。患者的中位年龄（IQR）为 69.5 岁（19.8），在调整 Cox 生存模型后死亡[RR=0.67，95%CI：0.46-0.97]。与对照组相比，干预组在 1 年内死亡的患者较少（7 例与 15 例）[RR=0.47，95%CI：0.20-1.06]。在 6 个月的随访期间，两组间的死亡率和再入院率无统计学差异。在长期随访中，医生开具的信息在降低心力衰竭患者的死亡率和再入院率方面具有临床和统计学意义。
